CRTC2 and type 2 diabetes mellitus: Thus, since diabetic hyperglycemia occurs when glucagon levels (or the physiological sensitivity to glucagon) increase and/or insulin levels (or sensitivity) decline16,17, strategies that manipulate the CREB/CRTC2 complex may be effective for the treatment of T2D.